Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1976-9-2
pubmed:abstractText
Under the conditions of our tests, ellipticine inhibits remarkably the carcinogenic action of BT6 on the liver, characterized, in particular, by the swiftness of its outbreak. Under the influence of this carcinostatic compound, a considerable activation of liver metabolism is observed, resulting in an hyperproduction of cytochrome P450, while the arginase capital is restored after an appreciable fall, as if ellipticine played a favourable part in the safeguard of this enzyme, recognized as one of the targets of liver carcinogens. The relationships between various effects of ellipticine are discussed.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0567-655X
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
282
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1219-24
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1976
pubmed:articleTitle
[Inhibitory effect of ellipticine (dimethyl-5,11-(6H) pyrido (4,3-b) carbazole on the induction of liver cancer by BT6 (N,N-dimethyl-p-(benzothiazolylazo) analine) and its effect on the levels of cytochrome P450 and arginase activity].
pubmed:publicationType
Journal Article, English Abstract